Stock Comparison
LLY vs NVO
Eli Lilly and Company and Novo Nordisk A/S side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$1.08T
$212.80B
P/E (TTM)
42.9
11.6
Forward P/E
31.1
14.3
Price/Sales
14.9
0.7
Price/Book
32.2
6.9
EV/EBITDA
28.8
8.5
Dividend Yield
0.55%
3.75%
Profitability
Net Margin
35.00%
37.20%
Operating Margin
49.40%
61.60%
Return on Equity
107.50%
71.40%
Return on Assets
20.70%
19.30%
Growth (YoY)
Revenue Growth
55.50%
24.00%
Earnings Growth
169.90%
67.10%
Price & Risk
Beta
0.5
0.3
52-Week High
$1,215.76
$68.49
52-Week Low
$619.40
$34.58
Analyst Target
$1,222.62
$46.86
Compare LLY and NVO your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.